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Abstract
How might the abortion experience look in a world without the existing regulatory constraints? This 
paper critically assesses the evidence about how a high-quality abortion experience might be achieved 
in the first trimester. There would need to be positive obligations on states in pursuance of women’s 
reproductive rights. The onus would be on states and state actors to justify interferences and constraints 
upon a woman’s right to terminate in the first trimester of her pregnancy. In this vision, abortion is 
person-centered and normalized as far as possible. High-quality information about abortion would be 
freely available through multiple sources and in varying formats. Whenever possible, abortion would 
happen in a place chosen by the woman, and in the case of medical abortion, could be self-managed 
with excellent clinical backup on hand should the need arise. The overarching purpose of this paper is 
to highlight the broader environment and framework of state obligations necessary to underpin the lived 
experience of abortion.
Sam Rowlands, LLM, MD, FRCGP, FFSRH is Visiting Professor in the Department of Medical Sciences and Public Health at Bournemouth 
University, Bournemouth, UK.
Jeffrey Wale, LLB, PhD, PGCE, FHEA, is Senior Lecturer in Law in the Department of Humanities and Law at Bournemouth University, 
Bournemouth, UK.
Please address correspondence to Sam Rowlands. Email: srowlands@bournemouth.ac.uk.
Competing interests: None declared. 
Copyright © 2020 Rowlands and Wale. This is an open access article distributed under the terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original author and source are credited. 
s. rowlands and j. wale / general papers, 237-249
238
J U N E  2 0 2 0    V O L U M E  2 2    N U M B E R  1   Health and Human Rights Journal
Introduction
Criminalization of abortion has well-known 
deleterious effects.1 Much has been written on 
decriminalization of abortion, specifying what 
legislation needs to be dismantled.2 In contrast, 
we adopt a ‘constructivist’ approach, looking at 
what is needed to support a high-quality abortion 
experience, drawing upon research and literature 
that includes the lived experience of women who 
have undergone abortion. We set aside regulatory 
constraints that could hinder progress toward 
giving people with a uterus (in the interest of brev-
ity, ‘women’ is used hereafter) the ability to freely 
choose how they respond to an unwanted pregnan-
cy. As far as possible, we have used a fresh sheet 
of paper. We take a ground-up approach, building 
from scratch and beginning with no abortion-spe-
cific laws at all. 
Although we use the term ‘abortion’ through-
out this paper, we recognize that this may be 
construed as a loaded term with preconceived 
connotations. In keeping with our constructivist 
approach, we use the term simply to denote the 
steps necessary to bring about the end of an estab-
lished pregnancy (that is, after implantation of the 
embryo). These steps would, in the ordinary course 
of events, result in ending the life of the unborn 
entity or entities.
Starting points and core assumptions
In this paper, we make several core assumptions. 
First, we assume that the state has unlimited 
resources to address its positive and negative ob-
ligations to pregnant women. Second, we assume 
that those resources are distributed fairly, justly, 
and equally within society. Third, we make no at-
tempt to accommodate the plurality in this vision. 
There is no sense that competing views require 
accommodation or that compromises are necessary 
in the regulatory rules. Fourth, our vision does not 
seek to erase the private sphere, or any socio-po-
litical objections to, or prejudices against abortion. 
Rather, our focus is on a world without pre-existing 
regulatory constraint on the choices that women 
can make in this context. Fifth, although gestation 
outside the womb may soon be possible (ectogen-
esis), we assume that some demand for abortion 
(as currently envisaged) will persist.3 Necessarily, 
these assumptions limit the transferability of this 
framework in the real world, but our intention is 
to encourage policy makers and reformers to think 
critically about the possibilities that a constructiv-
ist approach might offer should the opportunity 
arise for genuine reform. Further, our purpose is 
to highlight that in the absence of direct regulato-
ry constraints, it is the broader environment and 
framework of state obligations that underpin the 
lived experience of abortion.
Defining quality in abortion care is at an early 
stage, despite abortion being such a commonplace 
occurrence. There is no standardized, validated 
set of quality metrics for abortion as there are, 
for example, for maternity services.4 This paper 
does not focus on safety, effectiveness, timeliness, 
efficiency, and equitability; there is a considerable 
body of work on these.5 Instead, we concentrate 
on person-centeredness as a major ingredient of 
a high-quality abortion experience. Person/pa-
tient-centered care means an approach that informs 
and engages women (and partners, if appropriate) in 
their own individual health care and also to engage 
service users in health care service co-design.6 We 
assume that appropriate regulatory mechanisms re-
main in place to maintain the safety of all abortion 
services.7 
We do not assume that women will have di-
rect contact with health services. This is in line 
with current World Health Organization think-
ing, the general principles of self-care, and the 
experiences and perceptions of women who have 
undertaken self-management of medical abor-
tion.8 We do, however, acknowledge that there 
are still some research gaps on self-managed 
abortion; for example, how best to inform and 
support women in using the medicines safely and 
effectively and how to facilitate the community 
distribution of high-quality drugs and information.9 
 We know that many women have opted, for 
various reasons, for “informal sector” abortions, 
even when they are entitled to a legal abortion in 
the formal (approved) health sector.10 On the face of 
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it, this may seem like a second-best option, but as 
some women positively opt for self-managed abor-
tion at home, it is no longer an act of desperation: 
“self-managed abortion can be a source of reprieve 
or escape from … indignities of formal settings 
and experiences of shame and powerlessness with-
in them.”11 We regard self-managed first-trimester 
medical abortion (that is without attending a health 
facility)—following evidence-based regimens 
using drugs from approved sources, with full in-
formation—as safe. Self-management could be 
supplemented by advice from an approved authori-
ty such as a pharmacist or an appropriately trained 
community activist. 
Unless appropriately registered, licensed, and 
trained, procedures undertaken by informal abortion 
providers such as herbalists, street vendors, and tra-
ditional birth attendants are potentially unsafe. For 
the avoidance of any doubt, we are not seeking to 
directly constrain the choices of pregnant women. 
Rather, our concern is to ensure that women are not 
harmed or subjected to the unnecessary risk of sig-
nificant harm by the supply of inaccurate/ inadequate 
information or the provision of deficient abortion 
services. Accordingly, we suggest that informal ser-
vice providers, rather than pregnant women, should 
be the target of any future regulatory constraints. 
Our aim is to minimize recourse to untrained ser-
vice providers by delivering improved access to the 
formal (approved) and publicly funded sector. In our 
vision, the formal sector and those who work in it are 
subject to regulation in relation to the standard and 
quality of pre-/post-abortion care. 
When women are asked what they want in 
abortion services, they identify minimal delay as 
a priority.12 Women who have decided to termi-
nate a pregnancy want their abortion procedure 
to take place as soon as possible, and find a delay 
distressing.13 Most say they do not want counsel-
ing.14 Facilitating access to abortion services is an 
important aspect of our vision.
Although we do not rule out extension of our 
vision, we limit the immediate scope of this paper 
to first-trimester abortion due to the current insuf-
ficiency of evidence as to safety, effectiveness, and 
acceptability of second or third trimester medical 
abortion undertaken outside the formal health 
system. Although ambulatory (outpatient) medical 
abortion is generally limited to 10 weeks’ gestation, 
the envelope continues to be pushed on this upper 
limit. The World Health Organization recommends 
self-managed medical abortion up to 12 weeks’ 
gestation, conceding that evidence is limited for the 
upper two weeks.15 Further, we are on slightly eas-
ier ethical ground in the first trimester, whether on 
a rights, personhood, or relational perspective. Our 
starting point is that state actors have a much hard-
er time justifying constraints on pregnant women 
during the first trimester, partly because there is 
more common ground about the moral status of the 
unborn entity at this stage of development. Conse-
quently, any margin of appreciation that might be 
granted to states and their agents ought to be nar-
rowly construed during this stage of pregnancy.16 
Some of the thinking behind this paper has 
been stimulated by innovative organizations that 
provide internet-based abortion services and there-
by empower women.17 Although women choose to 
use these services, the organizations only provide 
medical abortion and so by definition offer no 
choice within their service provision. Although 
the development of drugs for medical abortion has 
been a revolutionary scientific advance, in many 
high-resource countries medical abortion now 
tends to dominate service provision to the exclu-
sion of surgery.18 Surgery obviously requires direct 
contact with health professionals. But first-trimes-
ter surgical abortion can be provided safely outside 
a hospital setting with simple equipment, and sat-
isfaction with manual vacuum aspiration is high.19 
However, unless aspiration is available on demand, 
it is not a genuine option; for example, a weekly 
operating list is not sufficient.
The role of the state
All people have the right to expect quality health 
care from the state. But what exactly are the obli-
gations of the state in pursuance of this right? The 
reproductive justice framework contends that there 
is a right to have a child, a right not to have a child, 
and a right to parent a child in a safe and healthy 
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environment.20 Access to reproductive services is a 
key component of this framework because “there 
is no choice where there is no access.”21 Under ex-
isting international human rights law, states have 
specific obligations to respect, fulfill, and protect 
human rights, including reproductive rights.22 
These obligations include limitations on the actions 
that states may take (negative obligations) and on 
proactive measures that states must take (positive 
obligations) to give effect to individual rights and 
freedoms. States must take steps towards fulfill-
ing their obligations by all appropriate means, 
including particularly the adoption of legislative 
measures, and should report on these measures 
and the basis on which they have been considered 
the most appropriate under the circumstances. 
States have three core obligations relating to 
abortion: a duty to respect, a duty to fulfill, and a 
duty to protect. In the following section, we outline 
how these obligations would work in our vision and 
offer some framework on scope.
The duty to respect requires states to refrain 
from interfering directly or indirectly with the 
enjoyment of reproductive rights unless that inter-
ference is justified, proportionate, and necessary to 
achieve a legitimate aim. Using the work of philos-
opher John Stuart Mill as our foundation, we argue 
that interference can only be justified or legitimate 
if it is necessary to prevent harm to others which 
is both morally indefensible and rights-violating.23 
Unless one subscribes to the view that the unborn 
entity is a rights-bearer in the first trimester, it 
would not be legitimate to interfere with a woman’s 
right to terminate at that stage in order to protect 
the unborn entity. We do not take an explicit po-
sition on such interferences in the later stages of 
the pregnancy but accept that there might be other 
legitimate reasons to interfere, or for a state to 
otherwise take responsibility. For example, where 
the harm or potential for harm arises from related 
technology that has been released and managed or 
controlled in a public health context; or where the 
dignity of humanity as a whole is at stake; or to 
preserve/protect the essential pre-conditions for 
human existence or any social human existence.24 
If we take the specific example of prenatal screen-
ing, a state may be responsible for the testing 
technology made available in publicly-funded ma-
ternity services. The state may also have reason to 
intervene where private sector providers promote 
testing and deselection of specific non-health-re-
lated characteristics.25 However, in these cases, the 
state and their agents would bear a heavy burden to 
justify any constraint on a woman’s reproductive 
rights in the context of abortion.
The duty to fulfill requires that states adopt 
whatever measures are necessary—legislative, bud-
getary, judicial, and/or administrative—to achieve 
the full realization of reproductive rights. This would 
include the provision of appropriate forums to re-
solve disputes and determine or enforce appropriate 
remedies. We address the funding of private sector 
provision below. As part of their obligations, states 
should ensure that reproductive health information, 
goods, and services are available, accessible, ac-
ceptable, and of good quality: AAAQ.26 
The duty to protect requires states to prevent 
third parties from infringing upon reproductive 
rights and to take steps to investigate and punish 
such violations when they occur. So, for example, 
anyone coercing or misleading a woman into an 
abortion or covertly inducing an abortion should 
be subject to some form of regulation. Similarly, 
any health professional acting in bad faith (for 
example, failing to obtain adequate consent or de-
livering poor standards of care) should be subject 
to some form of sanction. We can debate whether 
there should be disciplinary, civil, and/or criminal 
consequences in these circumstances. We should 
not criminalize human behavior unless absolutely 
necessary, and then only in a proportionate way. If 
we choose to direct sanctions against third parties, 
it may be preferable to use disciplinary or civil 
mechanisms before engaging the criminal law.
Under its duty to protect, the state should en-
sure that abortion providers do not infringe upon 
reproductive rights. Refusals to provide abortion 
care on grounds of conscience can compromise ac-
cess to abortion and harm health and well-being.27 
Such refusals are not permissible in emergency 
situations or by institutions; they are only valid 
in relation to direct provision of care and, in such 
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instances, referral must be made to an alternative 
willing and capable provider.28 Objector status 
should be disclosed at an early stage to employers 
and patients so that timely alternative plans can be 
made; in all regions of a country there must be ade-
quate numbers of health professionals who provide 
abortion care and the state must take measures to 
ensure that women’s access to legal abortion care is 
not undermined.29 Personal beliefs must not be pur-
sued where they are in conflict with the principles 
of good medical practice, where they cause patients 
to be treated unfairly, or where they deny patients 
access to appropriate treatment or services or cause 
distress.30 
Also, under its duty to protect, the state must 
ensure that members of the public with anti-choice 
views, while otherwise being permitted freedom of 
peaceful assembly, cannot infringe upon reproduc-
tive rights using intimidation and harassment close 
to abortion care facilities.31  Due to the distress wom-
en have experienced as a result of protests outside 
facilities in many countries, safe access zones are an 
absolute necessity to keep any protests away from 
facility entrances that women and providers use. 
Crisis pregnancy centers are run by non-med-
ical organizations; they attempt to intercept those 
seeking abortion and persuade them to continue 
the pregnancy.32 Under its duty to protect, the state 
must ensure that crisis pregnancy centers do not 
jeopardize women’s health, disseminate misinfor-
mation, and target marginalized groups.33 
The essential ingredients that facilitate a 
positive high-quality abortion experience
In this section, we identify the fundamental 
ingredients of a positive high-quality abortion 
experience. Some of these are not applicable to 
women who self-manage their abortion.
Person-centeredness
In a person-centered approach, care is individu-
alized and tailored to women’s preferences. It is 
acknowledged that there is no joy in the context of 
abortion—as with miscarriage and ectopic preg-
nancy and in stark contrast to childbirth.34 Women 
can choose how their first-trimester abortion is 
carried out and their degree of presence; some pre-
fer to be awake and experience it, some prefer to 
be sedated. Women can have privacy and discreet 
care; they may fear judgment when grouped with 
others undergoing abortion.35
The needs and rights of the pregnant woman 
are at the center of policymaking, information, 
service delivery, and one-on-one consultations. A 
person-centered framework and culture supports 
every person on their journey.36 Person-centered-
ness was identified as a key dimension of quality 
health care by the Institute of Medicine and further 
developed into a framework of eight domains for 
maternity care by Sudhinaraset et al.; Altshuler and 
Whaley adapted this structure for abortion care.37 
There is inevitably some overlap between these 
domains. The priority rights at the heart of this 
framework, and our wider discussion in this sec-
tion, are the rights to individual autonomy, human 
dignity, and privacy. Many of our points (including 
domains 4–8 below) are drawn from these priority 
rights. This overarching framework is facilitated 
and realized by engagement of the state duties to 
respect, fulfill, and protect. The eight domains are: 
1. Dignity
Dignity refers to the ability of women to receive 
care in a respectful and caring setting. The care 
supports an individual’s self-respect. Any percep-
tion that this will not be the case can drive women 
into the informal sector where the informational 
framework may be less reliable; or they may self-in-
duce abortion without sufficient back-up.
2. Autonomy
Human rights considerations dictate that autono-
my is the overriding determinant when choices are 
made in early pregnancy. This takes into account 
women’s embodied experience of being pregnant. 
The two basic requirements for autonomy are agen-
cy (the capacity for intentional action) and liberty 
(freedom from controlling influences exerted by 
external sources).38 Women should have control 
over their bodies and be free to make choices and 
decisions without external constraint in the first 
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trimester of their pregnancies. The consent process 
should be valid. Providers convey to women that 
they are seen as moral agents, capable of making 
decisions about their bodies and lives.39 
3. Privacy
Again, we are not attempting to expunge the dis-
tinction between the public and private spheres 
entirely, although the former is necessarily limited 
in our vision. Opting for an abortion is an intensely 
private matter. This includes physical privacy in the 
treatment setting and the confidentiality of sensi-
tive medical information. Physical examinations 
should be carried out discreetly. Some women pre-
fer to travel out of their area of residence in order 
to maintain anonymity. Some may prefer self-man-
aged abortion, perhaps with external support, 
because it offers greater privacy.
4. Communication
Treatment options are fully explained and dis-
cussed; women participate actively. The woman’s 
preferences, needs, and context are taken into 
account. Non-directive counseling is available, if 
sought, before and after the procedure or medical 
administration.
5. Support
This needs to be individually tailored as women 
differ greatly in the degree of support they desire. 
Some women are grateful not to be questioned too 
much. Others welcome some acknowledgment of 
the emotions they are grappling with, or possibly 
some discussion of them; these might be contradic-
tory emotions (ambivalence) or existential issues 
that can be triggered, such as life and death, moral-
ity, and meaning.40 While some women want to be 
alone, many value the support of a companion of 
their choice. Support should extend into the work-
place, so that women are guaranteed time off work 
without probing into their rationale or purpose.41 
An important resource for support is the volunteer 
abortion doula or pregnancy companion. Many 
doulas are “full spectrum,” meaning they will 
attend a woman during any pregnancy event, in-
cluding childbirth.42 Doulas offer compassionate 
care and are trained to counter stigma. Women 
overwhelmingly recommend doula support for 
abortion care, despite the fact that such support 
is not associated with measurable effects on phys-
ical comfort or emotional responses.43 Clinic staff 
believe doulas contribute to more patient-centered 
care.44 
6. Compassionate care
Care is provided in a compassionate manner.45 It is 
responsive to the person’s specific needs. Such care 
protects women from distress, pain, or harm. Small 
gestures can make an enormous difference.46 
7. Trust
Trust comprises how women assess the delivery of 
care by a specific provider in terms of their honesty 
and how confident service users feel about the pro-
vider’s competence.
8. Health facility environment
This domain includes comfort, cleanliness, ade-
quacy of equipment, and a pleasant environment. 
As well as the physical environment, this includes 
human aspects such as a supportive and non-judge-
mental atmosphere. Women sometimes have 
preconceived ideas about the appearance of a clinic 
and may be surprised by the cleanliness of their 
surroundings or facilities, for example.47 In our vi-
sion, there are no Targeted Regulation of Abortion 
Providers laws (that is, burdensome and medically 
unnecessary legal requirements that target abor-
tion providers).48 For example, requirements suited 
to hospital surgical facilities may be imposed which 
are far in excess of those needed for the relatively 
‘low-tech’ nature of abortion procedures.
Normalization
There are two aspects to the normalization of 
abortion. The first is full integration of abortion 
into health care as a mainstream service and, more 
particularly, as part of comprehensive sexual and 
reproductive health care.49 This should render ap-
proved private-sector provision (that is, those not 
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publicly funded) unnecessary, but we would not 
outlaw these providers unless there were conse-
quential considerations undermining public access. 
In any event, approved private sector provision 
would not be available on more favorable terms 
than public services.
The second is normalization with respect 
to society. Abortion is mostly subject to negative 
framing in the media. There are associations with 
controversy, sensationalism, and immorality.50 
There are also associations with ‘deviant’ prac-
tices such as teenage pregnancy and undesirable 
characteristics such as promiscuity; these tend to 
stereotype and falsely marginalize women who 
have abortions.51 
Despite a broad social narrative that abortion 
is by default negative, many women undergoing 
abortion say it is the right choice for them; some 
even call it a positive experience.52 Language used to 
describe their experiences can be non-negative but is 
often intertwined with negative framings. Neverthe-
less, negativity can be resisted and rejected. 
Normalizing representations of abortion 
can help destigmatize the practice.53 For example, 
Australian abortion clinic websites unapologeti-
cally present “a uniformly clear set of values and 
practices: a woman’s competency and ownership 
of decisions relating to her pregnancy; her entitle-
ment to good quality non-judgmental care; and the 
generally positive effects of an abortion.”54 This es-
tablishes “women’s position as the rightful subjects 
of abortion decisions and constructs abortion as 
a normal, positive and straightforward procedure 
that enables women to lead the lives they imagine 
for themselves.”55 
Feminist groups supporting women in 
self-managed abortion are driving a reduction in 
stigma. They share a belief “that every person who 
comes to them has the capacity and right to a safe 
and dignified abortion informed by the values and 
needs most important to them.”56 
Place of choice
Care closer to home as a means of contributing to 
the delivery of person-centered care has been in the 
sight of enlightened health professionals for some 
years, but unnecessary restrictions have got in the 
way.57 Absent such restrictions, including those 
governing where the medicines are administered, a 
woman can use both mifepristone and misoprostol 
in the “safety and security” of her home, the home 
of someone of her choice, or a place of safety.58 She 
can also choose who is present in that setting to 
support her. Those conducting their abortion at 
home need sufficient information that can alert 
them to medical conditions which would make 
them high-risk and therefore in need of medical 
advice and supervision. We would not seek to 
constrain the choices of the high-risk patient, but 
we would want to ensure that they were adequately 
informed and supported. Information provided 
would also ensure that women understand what 
symptoms should trigger contact with medical ser-
vices. A few women request inpatient care because 
they do not feel safe at home, and this needs to be 
accommodated.
For those accessing formal health services, we 
envisage woman obtaining their abortions locally, 
without extended travel possibly entailing crossing 
borders.59 Ideally, care could be accessed in a local 
health center, and at the nearest hospital for those 
who need hospital care. Special arrangements are 
needed for sparsely populated areas such as north-
ern Canada and central Australia, and for remote 
communities with no road/rail links. In such cases, 
clinicians can provide medical abortion via tele-
medicine; this service delivery is effective, safe, and 
has a high satisfaction rating.60 
Reproductive health commodity supply and 
security
In our vision, mifepristone is licensed in all coun-
tries. It is currently licensed in only 68 of the 193 
countries in the world (35%).61 Our vision would 
supplant the current situation, in which millions 
use the less-effective misoprostol-only regimen.
Secure systems are in place for procuring 
abortion pills and appropriate pregnancy tests 
for follow-up after abortion from reliable sourc-
es: mainly internet-based abortion services and 
accredited pharmacies.62 These systems would su-
persede widespread circulation of substandard and 
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counterfeit medicines and other medical products; 
such medicines include inactive substances, impure 
products, toxic substances, or other substances 
entirely.63 Pharmacy supplies can be provided at 
a distance; an example of regulations applying to 
such activity is that issued by the UK General Phar-
maceutical Council.64 
In our vision, over-the-counter status for 
mifepristone and misoprostol is operational. Only a 
small amount of additional information would need 
to be gleaned about self-administration of mifepri-
stone/misoprostol in order to make an application 
to the US Food and Drug Administration for over-
the-counter approval.65 Mechanisms for community 
pharmacy provision have been elaborated.66 
Information
The motto “knowledge is power” has become a 
cliché but is nevertheless true. Easy access to accu-
rate and clear information is a key element of our 
vision. Information is supplied in varied forms to 
suit different individuals. Animated films, as well 
as pictures and diagrams, supplement the written 
word.67 Access to this information is in a variety 
of modes including print, audio, and electronic. 
Abortion hotlines providing information based on 
official World Health Organization protocols play 
an important role. They release reliable information 
into the public domain where people can share it.68 
It is important that relevant information is made 
available that speaks to all, including any margin-
alized/intersectional groups and individuals.
What explicit information would be made 
available? First, the actual choice available would 
be spelled out. Except where there are medical 
contraindications, of which there are few, wom-
en could freely choose the options of medical or 
surgical abortion. Early surgical abortion in the 
form of manual vacuum aspiration is available 
without delay and not necessarily in a hospital 
setting.69 Manual vacuum aspiration is available 
from a range of providers, including nurses, mid-
wives, and general practitioners.70 There are many 
websites offering science-based information about 
self-managed medical abortion.
Second, information about local support 
would be accessible. This includes emotional, so-
cial, and financial support. 
Third, there would be information about the 
need for Rhesus disease prophylaxis after 10 weeks’ 
gestation for those who are Rhesus negative, when 
antibiotic prophylaxis is recommended, and which 
medical conditions require special precautions and 
medical input.71 
Fourth, there is good information about what 
to expect when undergoing an early medical abor-
tion and what human resources can be called upon, 
such as doulas.72 
Finally, information about contraception is 
freely available, together with the recommended 
timing of initiation after abortion.73 There is free-
dom of choice: no disproportionate emphasis on 
long-acting reversible contraception and no coer-
cion in relation to sterilization.74 
Clinical excellence
In our vision, clinicians are still needed to provide 
expertise in complex medical situations, to provide 
surgical services, and as a back-up for self-managed 
medical abortion; the number of such professionals 
is scaled down by adding a more varied skill mix. 
Policy makers and managers ensure there are suf-
ficient trained professionals, an even geographical 
spread of services, hygienic facilities, and ongoing 
focused capacity building.75 Careful service design 
ensures availability and accessibility. Waiting times 
operate according to specified national standards.76 
Services are operated in a variety of settings in-
cluding community facilities.77 Acceptability is 
continuously monitored.
Telephone advice and emergency consulta-
tion at a local medical facility would be available 
24 hours a day. Women are given an idea of how 
much bleeding to expect. The direct experience 
of pain and bleeding can be distressing and often 
some discussion and reassurance from an adviser 
is all that is needed, so direct live contact by phone, 
video link, or web-based chat is available. Compli-
cations are inevitable and experienced staff need to 
be on hand to deal with these.
Task shifting or sharing optimizes the roles of 
health care staff.78 Few abortions need to be provided 
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by gynecologists.79 General practitioners play a sig-
nificant role in service delivery.80 So-called mid-level 
providers (nurses, midwives, and physician assis-
tants) can safely provide both medical and surgical 
abortion.81 Pharmacists and pharmacy workers are 
able to safely provide medical abortion.82 
It is envisaged that many women will practice 
self-care. It has been demonstrated that self-man-
aged early medical abortion is mostly equivalent 
to that which is medically supervised, in terms of 
success rates and safety outcomes. Rates of incom-
plete abortion requiring surgical evacuation are 
somewhat higher, which may be because of care 
provision by clinicians with little experience in 
settings where abortion is legally restricted.83 
Women obtain abortion pills through phar-
macies or other reliable sources for self-managed 
abortion.84 Self-care has equal status to clini-
cian-provided care among health and regulatory 
systems.
Funding
Many studies report financial barriers to access to 
abortion.85 In our vision, women are not expected 
to rely on charity for such an important component 
of health care. Some women will have health insur-
ance which may cover abortion. Although women 
would be at liberty to pay for private services if 
they wished to, drugs, materials, and fees are all 
covered by the state for anyone, regardless of their 
citizenship status. Such cover is the same for any 
pregnancy outcome (delivery of any type, miscar-
riage, or ectopic pregnancy). Travel costs are paid 
by the state when necessary, for example, for people 
on state benefits or in a low-income bracket.86 
Conclusion
We have proposed a vision where there are ob-
ligations on the state in pursuance of women’s 
reproductive rights under the headings of duties 
to respect, fulfill, and protect. We recognize that 
this imagined world is far from current reality 
and might never be achieved. So, why bother to 
formulate such a vision? Many of us have spent con-
siderable time addressing the existence and scope 
of individual rights/freedoms, and on the possible 
deconstruction of existing regulatory constraints 
in the context of abortion. We do not besmirch or 
seek to undermine these efforts. Rather, our cen-
tral purpose in this paper is to shift attention away 
from discussions about the lawfulness of abortion. 
By starting from a world without constraints, the 
primary focus turns to the environment and frame-
work of state obligations in which abortion services 
are accessed and delivered. It is these background 
factors that provide the critical foundation for the 
realization of individual rights and freedoms. Any 
reformist agenda should never lose sight of this.
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